PTC Therapeutics
PTCT
#3695
Rank
โ‚น236.45 B
Marketcap
โ‚น3,074
Share price
1.33%
Change (1 day)
48.97%
Change (1 year)

Revenue for PTC Therapeutics (PTCT)

Revenue in 2024 (TTM): โ‚น74.99 B

According to PTC Therapeutics 's latest financial reports the company's current revenue (TTM) is โ‚น75.54 B. In 2023 the company made a revenue of โ‚น78.07 B an increase over the revenue in the year 2022 that were of โ‚น57.82 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PTC Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น74.99 B-3.94%
2023 โ‚น78.07 B35.01%
2022 โ‚น57.82 B44.07%
2021 โ‚น40.13 B44.38%
2020 โ‚น27.80 B27.23%
2019 โ‚น21.85 B18.66%
2018 โ‚น18.41 B48.36%
2017 โ‚น12.41 B120.85%
2016 โ‚น5.62 B115.51%
2015 โ‚น2.60 B79.45%
2014 โ‚น1.45 B-24.93%
2013 โ‚น1.93 B22.84%
2012 โ‚น1.57 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น867.24 B 1,048.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น126.25 B 67.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.03 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.88 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.20 B-85.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.099 T 5,326.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland